(Q39271087)

10 September 2017

title

Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells (English)

1 reference

10 September 2017

0 references

0 references

5

0 references

author name string

Virginia Alvarez-García

1

1 reference

10 September 2017

Alicia González

2

1 reference

10 September 2017

Carolina Alonso-González

3

1 reference

10 September 2017

Carlos Martínez-Campa

4

1 reference

10 September 2017

publication date

27 September 2012

1 reference

Journal of Pineal Research

10 September 2017

published in

1 reference

10 September 2017

volume

54

1 reference

10 September 2017

issue

4

1 reference

10 September 2017

page(s)

373-380

1 reference

Tumorigenesis and the angiogenic switch

10 September 2017

cites work

1 reference

The role of antiangiogenetic agents in the treatment of breast cancer.

21 January 2018

1 reference

Angiogenesis inhibitors: current strategies and future prospects

21 January 2018

1 reference

Vascular permeability factor (VPF, VEGF) in tumor biology

21 January 2018

1 reference

Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models

21 January 2018

1 reference

Melatonin and mammary pathological growth.

21 January 2018

1 reference

Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy

21 January 2018

1 reference

Melatonin and mammary cancer: a short review

21 January 2018

1 reference

Melatonin as a selective estrogen enzyme modulator.

21 January 2018

1 reference

Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells

21 January 2018

1 reference

Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.

21 January 2018

1 reference

Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.

21 January 2018

1 reference

Aromatase excess in cancers of breast, endometrium and ovary

21 January 2018

1 reference

Melatonin promotes differentiation of 3T3-L1 fibroblasts.

21 January 2018

1 reference

Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production

21 January 2018

1 reference

Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis

21 January 2018

1 reference

Basic fibroblast growth factor inhibits radiation-induced apoptosis of HUVECs. I. The PI3K/AKT pathway and induction of phosphorylation of BAD.

21 January 2018

1 reference

Heparanase induces endothelial cell migration via protein kinase B/Akt activation

21 January 2018

1 reference

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.

21 January 2018

1 reference

Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer

21 January 2018

1 reference

Sex steroid-producing enzymes in human breast cancer

21 January 2018

1 reference

The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer

21 January 2018

1 reference

Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-beta1 and TNF-alpha

21 January 2018

1 reference

Aromatase inhibitors and their application in breast cancer treatment*.

21 January 2018

1 reference

Melatonin-estrogen interactions in breast cancer.

21 January 2018

1 reference

Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells

21 January 2018

1 reference

Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin

21 January 2018

1 reference

Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects

21 January 2018

1 reference

Melatonin modulates the expression of VEGF and HIF-1 alpha induced by CoCl2 in cultured cancer cells

21 January 2018

1 reference

Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression

21 January 2018

1 reference

Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia

21 January 2018

1 reference

Increased vascular permeability and nitric oxide production in response to hypoxia in the pineal gland.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JPI.12007

1 reference

10 September 2017

1 reference